Effects of SMYD3 overexpression on transformation, serum dependence, and apoptosis sensitivity in NIH3T3 cells

IUBMB Life

Volumn 61, Issue 6, 2009, Pages 679-684

  Luo, Xue Gang ^a,b   Xi, Tao ^b   Guo, Shu ^a   Liu, Zhi Peng ^a   Wang, Nan ^a   Jiang, Yong ^a   Zhang, Tong Cun ^a  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Apoptosis sensitivity; NIH3T3 cells; Serum dependence; SMYD3; Transformation

Indexed keywords

AGAR; DEXAMETHASONE; HISTONE METHYLTRANSFERASE; SET AND MYND DOMAIN-CONTAINING PROTEIN 3; UNCLASSIFIED DRUG; HISTONE LYSINE METHYLTRANSFERASE; MESSENGER RNA; SMYD3 PROTEIN, HUMAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PHENOTYPE; ANIMAL; BIOSYNTHESIS; CELL STRAIN 3T3; CELL TRANSFORMATION; CULTURE MEDIUM; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; METABOLISM; SERUM;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CULTURE MEDIA; DEXAMETHASONE; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; MICE; NIH 3T3 CELLS; RNA, MESSENGER; SERUM; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 69449099439     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.216     Document Type: Article

References (21)

1. Gibbons, R.J. (2005) Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum. Mol. Genet. 14, R85-R92.
2. Lund, A.H., Lohuizen, M.V. (2004) Epigenetics and cancer. Gene Dev. 18, 2315-2335.
3. Schneider, R., Bannister, A.J., and Kouzarides, T. (2002) Unsafe SETs: histone lysine methyltransferases and cancer. Trends. Biochem. Sci. 27, 396-402.
4. Hamamoto, R., Furukawa, Y., Morita, M., Ilimura, Y., Silva, F.P., Li, M., Yagyu, R., and Nakamura, Y. (2004) SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat. Cell. Biol. 6, 731-740.
5. Sims, R.J. and Reinberg, D. (2004) From chromatin to cancer: a new histone lysine methyltransferase enters the mix. Nat. Cell. Biol. 6, 685-687.
6. Hamamoto, R., Silva, F.P., Tsuge, M., Nishidate, T., Katagiri, T., Nakamura, Y., and Furukawa, Y. (2006) Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer. Sci. 97, 113-118.
7. Xu, J.Y., Chen, L.B., Xu, J.Y., Yang, Z., Wei, H.Y., and Xu, R.H. (2006) Suppression of SMYD3 expression in HepG2 cell by shRNA interference. Zhonghua. Gan. Zang. Bing. Za. Zhi. 14, 105-108.
8. Xu, J.Y., Chen, L.B., Xu, J.Y., Yang, Z., Xu, R.H., and Wei H.Y. (2006) Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference. Zhonghua. Wai. Ke. Za. Zhi. 44, 481-484.
9. Xu, J.Y., Chen, L.B., Xu, J.Y., Yang, Z., Wei, H.Y., and Xu, R.H. (2006) Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2. Ai. Zheng. 25, 526-532.
10. Chomczynski P. (1993) A reagent for the single-step simultaneous isolation of RNA, DNA, and proteins from cell and tissue samples. Biotechniques 15, 532-536.
11. Sambrook, J. and Russell, D.W. (2002) Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor Laboratory Press, New York.
12. Hong, Y.K., Mikami, A., Schaffhausen, B., Jun, T., and Roberts, T.M. (2003) A new class of mutations reveals a novel function for the original phosphatidylinositol 3-kinase binding site. Proc. Natl. Acad. Sci. USA 100, 9434-9439.
13. Nagakubo, D., Taira, T., Kitaura, H., Ikeda, M. Tamai, K., Iguchi-Ariga, S.M.M., and Ariga, H. (1997) DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem. Biophys. Res. Commun. 231, 509-513.
14. Wang, C., Wang, J.H., Li, F., and Lu, J. (2003) The effects of inhibiting P18INK4C expression on the invasion of gastric adenocarcinoma cell line. Acta. Biochim. Biophys. Sin. 35, 511-517.
15. Cidlowski, J.A., King, K.L., Evans-Storms, R.B., Montague, J.W., Bortner, C.D., and Hughes, F.M.J. (1996) The biochemistry and molecular biology of glucocorticoid-induced apoptosis in the immune system. Recent. Prog. Horm. Res. 51, 457-490.
16. Kohl, N.E., Kanda, N., Schreck, R.R., Bruns, G., Latt, S.A., Gilbert, F., and Alt, F.W. (1983) Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35, 359-367. (Pubitemid 14202914)
17. Kato, G.J. and Dangt, G.V. (1992) Function of the c-Myc oncoprotein. FASEB J. 6, 3065-3072.
18. Small, M.B., Hay, N., Schwab, M., and Bishop J.M. (1987) Neoplastic transformation by the human gene N-myc. Mol. Cell. Biol. 7, 1638-1645.
19. Ueda, K. and Ganem, D. (1996) Apoptosis is induced by N-myc expression in hepatocytes, a frequent event in hepadnavirus oncogenesis, and is blocked by insulin-like growth factor II. J. Virol. 70, 1375-1383. (Pubitemid 26062893)
20. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z., and Hancock, D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128.
21. Nesbit, C.E., Grove, L.E., Yin, X., and Prochownik, E.V. (1998) Differential apoptotic behaviors of c-myc, N-myc, and L-myc oncoproteins. Cell. Growth. Differ. 9, 731-741.